Single-inhaler triple versus dual bronchodilator therapy for GOLD group E and other exacerbating patients with COPD: real-world comparative effectiveness and safety

被引：4
|
作者：
Suissa, Samy [1 ,2 ,3 ]
机构：
[1] Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ, Canada
[2] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[3] McGill Univ, Med, Montreal, PQ, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷 / 03期
关键词：
D O I：
10.1183/13993003.00883-2023
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] INFORMING THE PATHWAY OF COPD TREATMENT (THE IMPACT STUDY): SINGLE INHALER TRIPLE THERAPY (FF/UMEC/ VI) VERSUS DUAL BRONCHODILATOR THERAPY (UMEC/ VI) IN PATIENTS WITH COPD - COST-EFFECTIVENESS IN THE UK
    Anley, G.
    Shah, D.
    Schroeder, M.
    Ndirangu, K.
    Risebrough, N.
    Okorogheye, G.
    Fenwick, E.
    Martin, A.
    Ismaila, A. S.
    THORAX, 2018, 73 : A236 - A237
  • [42] Comparative Effectiveness of Triple Therapy versus Dual Bronchodilation in Elder Adults with Chronic Obstructive Pulmonary Disease (COPD): A Real-World Population Study
    Gershon, A. S.
    Jiang, L.
    Kendzerska, T.
    Tan, W.
    Stukel, T.
    Stanbrook, M. B.
    Aaron, S. D.
    Pequeno, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [43] Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]
    Strange, C.
    Tkacz, J.
    Schinkel, J.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 1799 - 1799
  • [44] Trioptimize VI: The Use of Extrafine Single Inhaler Triple Therapy Improves Adherence to Treatment in Patients with COPD - Real-World Evidence
    Hoevelmann, R.
    Georges, G.
    Javan, S. Bahari
    Melchior, K.
    Criee, C.
    Gessner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [45] REDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS AFTER SWITCH FROM DUAL THERAPY TO SINGLE-INHALER TRIPLE THERAPY IN A REAL-WORLD HEALTH CARE SETTING IN THE US
    McCormack, Meredith C.
    Noorduyn, Stephen G.
    Gronroos, Noelle
    Lee, Lydia
    Johnson, Mary
    Wrobleski, Kristin
    Veeranki, Phani
    Ismaila, Afisi S.
    Igboekwe, Emmeline
    Paczkowski, Rosirene
    CHEST, 2023, 164 (04) : 4942A - 4943A
  • [46] Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
    Sandeep Bansal
    Martin Anderson
    Antonio Anzueto
    Nicola Brown
    Chris Compton
    Thomas C. Corbridge
    David Erb
    Catherine Harvey
    Morrys C. Kaisermann
    Mitchell Kaye
    David A. Lipson
    Neil Martin
    Chang-Qing Zhu
    Alberto Papi
    npj Primary Care Respiratory Medicine, 31
  • [47] Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
    Bansal, Sandeep
    Anderson, Martin
    Anzueto, Antonio
    Brown, Nicola
    Compton, Chris
    Corbridge, Thomas C.
    Erb, David
    Harvey, Catherine
    Kaisermann, Morrys C.
    Kaye, Mitchell
    Lipson, David A.
    Martin, Neil
    Zhu, Chang-Qing
    Papi, Alberto
    NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2021, 31 (01)
  • [48] REDUCED HEALTH CARE RESOURCE UTILISATION AND COSTS FOLLOWING A SWITCH FROM MULTIPLE-INHALER TO ONCE-DAILY SINGLE-INHALER TRIPLE THERAPY IN COPD PATIENTS IN A REAL-WORLD PRIMARY CARE SETTING IN ENGLAND
    Rothnie, K. J.
    Wood, R. P.
    Czira, A.
    Banks, V. L.
    Cammidge, L. J.
    Massey, O. K.
    Seif, M.
    Compton, C.
    Sharma, R.
    Ismaila, A. S.
    VALUE IN HEALTH, 2022, 25 (12) : S484 - S484
  • [49] Trioptimize V: Improvement of Air Flow and Resistance in Patients with COPD Treated with Extrafine Single Inhaler Triple Therapy in a Real-World Setting
    Georges, G.
    Criee, C.
    Hoevelmann, R.
    Javan, S. Bahari
    Melchior, K.
    Gessner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [50] Exacerbations and Real-world Outcomes (EROS) Among Patients With COPD Receiving Single Inhaler Triple Therapy of Budesonide/glycopyrrolate/formoterol Fumarate
    Pollack, M.
    Tkacz, J. P.
    Schinkel, J.
    Lewing, B.
    Agatep, B.
    Swisher, S.
    Patel, S.
    Edwards, D.
    Touchette, D.
    Portillo, E.
    Feigler, N.
    Strange, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
12345